CVE-2011-3386: Medtronic Paradigm Wireless Insulin Pump

Medium severity, CVSS 4.0. EPSS: 1.5% chance of exploitation in the next 30 days.

Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly."

Affected products

• Medtronic Paradigm Wireless Insulin Pump: version 512 only; version 522 only; version 712 only; version 722 only

Published 2011-09-02. Last modified 2026-06-16.